Mayo Clinic researchers have identified a targeted therapy that could bring relief to people living with lichen planus, a chronic inflammatory skin condition of the skin, hair, nails, mouth and ...
“In addition to decreasing the inflammation by decreasing lesional staphylococcus aureus, the mupirocin treatment also lowered skin monocyte levels, which are important in driving cutaneous lupus,” ...
These suggest the potential of a repurposed marketed drug to modulate inflammation through a newly ... has prompted growth in the allergy treatment market, which Imarc Group projects will expand ...